ES2099247T3 - Iloprost con efecto contra la malaria cerebral. - Google Patents

Iloprost con efecto contra la malaria cerebral.

Info

Publication number
ES2099247T3
ES2099247T3 ES92904592T ES92904592T ES2099247T3 ES 2099247 T3 ES2099247 T3 ES 2099247T3 ES 92904592 T ES92904592 T ES 92904592T ES 92904592 T ES92904592 T ES 92904592T ES 2099247 T3 ES2099247 T3 ES 2099247T3
Authority
ES
Spain
Prior art keywords
iloprost
effect against
against brain
brain malaria
pct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92904592T
Other languages
English (en)
Inventor
Eveline Dr Blitstein-Willinger
Karen Sliwa-Henle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2099247T3 publication Critical patent/ES2099247T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION DESCRIBE LA APLICACION DE ILOPROST PARA LA PRODUCCION DE UNOS MEDIOS PARA EL TRATAMIENTO DE LA MALARIA CEREBRAL.
ES92904592T 1991-02-12 1992-02-07 Iloprost con efecto contra la malaria cerebral. Expired - Lifetime ES2099247T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4104606A DE4104606C1 (es) 1991-02-12 1991-02-12

Publications (1)

Publication Number Publication Date
ES2099247T3 true ES2099247T3 (es) 1997-05-16

Family

ID=6425074

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92904592T Expired - Lifetime ES2099247T3 (es) 1991-02-12 1992-02-07 Iloprost con efecto contra la malaria cerebral.

Country Status (12)

Country Link
US (1) US5466713A (es)
EP (1) EP0571457B1 (es)
JP (1) JP3322311B2 (es)
KR (1) KR100188164B1 (es)
AT (1) ATE147628T1 (es)
AU (1) AU663484B2 (es)
CA (1) CA2103906C (es)
DE (2) DE4104606C1 (es)
DK (1) DK0571457T3 (es)
ES (1) ES2099247T3 (es)
GR (1) GR3022870T3 (es)
WO (1) WO1992013537A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4124695C2 (de) * 1991-07-22 1994-12-22 Blitstein Willinger Eveline Dr Verwendung von Carbacyclinderivaten zur Behandlung von Psoriasis vulgaris
DE4226615C1 (de) * 1992-08-07 1994-05-19 Schering Ag Verwendung von Prostan-Derivaten zur Behandlung von chronischer Polyarthritis
EP1596858A1 (en) * 2003-02-14 2005-11-23 Medical Research Council Ip receptor antagonists for the treatment of pathological uterine conditions
ES2622471T5 (es) 2003-05-22 2020-07-23 United Therapeutics Corp Compuestos y procedimientos para la administración de análogos de prostaciclina
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
CN101903324B (zh) 2007-12-17 2013-07-03 联合治疗公司 一种制备Remodulin中的活性成分曲前列素的改良方法
BR112014018970A8 (pt) * 2012-02-02 2017-07-11 Becton Dickinson Co Dispositivos de coleta de amostra com agentes de estabilização sanguínea
JP2016517410A (ja) 2013-03-14 2016-06-16 ユナイテッド セラピューティクス コーポレイション トレプロスチニルの固体形態
US9593061B2 (en) 2014-10-20 2017-03-14 United Therapeutics Corporation Synthesis of intermediates for producing prostacyclin derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2845770A1 (de) * 1978-10-19 1980-04-30 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
DE3121155A1 (de) * 1981-05-22 1982-12-09 Schering Ag, 1000 Berlin Und 4619 Bergkamen Neue carbacycline, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3608088C2 (de) * 1986-03-07 1995-11-16 Schering Ag Pharmazeutische Präparate, enthaltend Cyclodextrinclathrate von Carbacyclinderivaten

Also Published As

Publication number Publication date
EP0571457A1 (de) 1993-12-01
CA2103906A1 (en) 1992-08-13
US5466713A (en) 1995-11-14
KR100188164B1 (en) 1999-06-01
GR3022870T3 (en) 1997-06-30
DE4104606C1 (es) 1992-10-15
ATE147628T1 (de) 1997-02-15
AU1237592A (en) 1992-09-07
AU663484B2 (en) 1995-10-12
JPH06507380A (ja) 1994-08-25
JP3322311B2 (ja) 2002-09-09
EP0571457B1 (de) 1997-01-15
DK0571457T3 (da) 1997-07-14
CA2103906C (en) 2003-06-03
WO1992013537A1 (de) 1992-08-20
DE59207900D1 (de) 1997-02-27

Similar Documents

Publication Publication Date Title
IN172468B (es)
DE68929540D1 (de) Substituierte Phenylpyrimidine Derivate, für die Behandlung oder Prevention von ZNS-Erkrankungen
UA27911C2 (uk) Засіб для лікування або запобігання фізіологічних розладів, які викликані надлишком тахікініну
ATE368660T1 (de) Verfahren zur herstellung von enantiomerisch reine beta-d-dioxolan-nukleoside
HUT64310A (en) Compositions containing substituted aryl-halogenalkyl-pyrazol derivatives having herbicidal activity and process for producing said compounds
HU912272D0 (en) Process for the production of 2,6-dialkyl-4- silil-phenol derivatives
HUT44472A (en) Process for production of derivatives of /phenil or alkyl-oxo/-phenol with lenhotrien antagonistic effect
YU48666B (sh) Mometason furoat monohidrat i postupak za njegovo dobijanje
EP0444196A4 (en) Agent for treatment and prophylaxis of ischemic disease of heart or brain
MY107573A (en) 2,4- and 2, 5-substituted pyridine-n-oxides, processes for their preparation and their use.
ES2099247T3 (es) Iloprost con efecto contra la malaria cerebral.
ES2079872T3 (es) Derivados hipotensores oculares de la 2-descarboxil-2-aciltioalquilprostaglandina.
AU634003B2 (en) 4-benzyl-5-phenyl-2,4-dihydro-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
PH24094A (en) 5-aryl-3h-1,2,4-triazol-3-ones and their use as anticonvulsants
EP0116628A4 (en) 1-ACYL-3-PYRIDYLMETHYLGUANIDINE AND THEIR USE AS AN ANI-HYPERTENSIVE.
HUT61197A (en) Process for producing composition against metastasis
WO1992010473A3 (en) 2-decarboxyl-2-alkoxyalkyl prostaglandins as ocular hypotensives
IT8468265A1 (it) Derivati del 3-fenil-4H-1-benzopirano-4-one per la prevenzione o il trattamento dell'osteoporosi.
MX9602767A (es) Dimaleato de n,n-dietil-8,8-dipropil-2-azaspiro[4,5]decano-2-propanamina.
EP0146711A3 (en) 2-hydrazino-1h-imidazoles
ES1018239Y (es) Ensamblador para la fabricacion de marcos.
IT1228930B (it) Diclorotrifluorometilnitrotolueni e loro conversione in aminotrifluorometiltolueni
UA41496A1 (uk) Спосіб кування злитку
AR240397A1 (es) Banera para aplicacion de hidromasajes por burbujeo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 571457

Country of ref document: ES